Plus Therapeutics Inc (NASDAQ:PSTV) price on Thursday, March 20, rose 170.06% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $1.38.
A look at the stock’s price movement, the close in the last trading session was $0.51, moving within a range at $0.5502 and $2.08. The beta value (5-Year monthly) was 0.731. Turning to its 52-week performance, $2.67 and $0.24 were the 52-week high and 52-week low respectively. Overall, PSTV moved 15.00% over the past month.
Plus Therapeutics Inc’s market cap currently stands at around $16.26 million, with investors looking forward to this quarter’s earnings report slated for on 2024-Nov-13.
The average forecast suggests down to a -9.18% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 5.53M, representing a 12.52% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that PSTV is a 50% Sell. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in Hold category.
PSTV’s current price about 51.02% and 26.41% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 57.69, while 7-day volatility ratio is 71.73% and 55.48% in the 30-day chart. Further, Plus Therapeutics Inc (PSTV) has a beta value of 0.97, and an average true range (ATR) of 0.35.
If we refocus on Plus Therapeutics Inc (NASDAQ:PSTV), historical trading data shows that trading volumes averaged 50.58 over the past 10 days and 8.81 million over the past 3 months. The company’s latest data on shares outstanding shows there are 5.90 million shares.
The 2.55% of Plus Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 11.50% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.14 million on 2025-02-28, giving us a short ratio of 1.23. The data shows that as of 2025-02-28 short interest in Plus Therapeutics Inc (PSTV) stood at 243.00002000000003 of shares outstanding, with shares short rising to 88408.0 registered in 2025-01-31. Current price change has pushed the stock 20.00% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the PSTV stock continues to rise going into the next quarter.
